AI Maverick Intel Signs Definitive Deal to Acquire Heal Access Platform
AI Maverick Intel, Inc. (OTC:AIMV) signed a definitive share purchase agreement to acquire Heal Access Canada Inc., a developer of an artificial intelligence healthcare platform. Under the agreement, AI Maverick Intel will acquire the enterprise from its controlling stockholder, HEAL Group Holdings Inc.
The transaction carries a purchase price of $5 million satisfied through a two-year, 10% secured promissory note issued at closing, alongside 20 million exchangeable shares. AI Maverick Intel will also assume approximately $6.4 million in debt that Heal Access owes to HEAL Group Holdings Inc. Heal Access currently runs its software platform across five international markets, serving more than 118,000 patients.
To complete the acquisition, AI Maverick Intel must raise or secure binding commitments for at least $6 million in financing on or before December 31, 2026. The transaction remains subject to approval by an independent special committee of the company's board, with a final long-stop closing date of February 28, 2027.
Key points
- AI Maverick Intel, Inc. (OTC:AIMV) signed a definitive agreement to acquire healthcare AI platform Heal Access Canada Inc. from HEAL Group Holdings Inc.
- Consideration consists of a $5 million two-year promissory note, 20 million exchangeable shares, and the assumption of approximately $6.4 million in debt.
- Deal completion requires AI Maverick Intel to secure at least $6 million in financing by December 31, 2026, and obtain independent committee approval.
- Heal Access provides an agentic AI engine serving over 118,000 patients across five countries, including the U.S., Canada, and the U.K.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What company is AI Maverick Intel acquiring?
AI Maverick Intel, Inc. (OTC:AIMV) is acquiring Heal Access Canada Inc., an agentic healthcare AI platform operating in five countries with over 118,000 active patients.
What are the financial terms of the acquisition?
The purchase price includes a $5 million secured promissory note with 10% annual interest due in two years and 20 million exchangeable shares, along with assuming about $6.4 million in debt.
What conditions are needed for the deal to close?
AI Maverick Intel must raise or secure commitments for at least $6 million in financing by December 31, 2026, and receive ratification from an independent special board committee.